Get the content you want anytime you want.
IDWeek 2019

Select coverage from IDWeek 2019 is included below:

Keith S. Kaye, MD, MPH: RESTORE-IMI 2 and Treating Critically Ill Patients With Respiratory Infections
Keith S. Kaye, MD, MPH, discusses the current treatment landscape for pneumonia in the ICU setting, and previews the topline results of the phase 3 RESTORE-IMI 2 trial.
Anandi Sheth, MD, MSc: HIV Prevention in Women
Anandi Sheth, MD, MSc, summarizes her presentation on HIV prevention in women and discusses the need for more women in pre-exposure prophylaxis research.
Why Do We Need NICU Stewardship?
Pablo J. Sánchez, MD, discusses the need for NICU stewardship with Debra Goff, PharmD, and Pavel Prusakov, PharmD. 
Getting Ahead of <i>Candida auris</i>: Tales from IDWeek 2019
Health officials provide 4 strategies to improve C auris surveillance efforts.
DBS Testing in Infants May Miss Congenital Cytomegalovirus
Newborn dried blood spot testing is not sensitive enough to diagnose all cases of congenital cytomegalovirus (cCMV) in infants with sensorineural hearing loss.
The Seattle Flu Study: Mapping the Spread of Influenza
Helen Chu, MD, MPH, discussed the "Seattle Flu Study" with Contagion at IDWeek 2019.
What to Expect in October's News and Breakthroughs
Elizabeth Hirsch, PharmD, previews her piece with Mélanie Mahoney, PharmD student, on 2019 updates to CLSI breakpoints.
Community-Based HIV Care for MSM, Transgender Women As Effective as Hospital-Based Care
University of Illinois at Chicago investigators compared virologic failure among MSM and transgender women receiving HIV care at a community-based model with those receiving care at a hospital-based model.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?